Research and Development

PharmaTher is focused on the research and development of psychedelic pharmaceuticals for FDA approval by finding new uses and drug combinations with panaceAI™ our artificial intelligence drug repurposing platform, novel delivery systems.  We are building our product pipeline that targets disorders of the brain and nervous system, which will benefit from the attractive regulatory incentives for expedited approvals, such as the FDA 505(b)(2) regulatory pathway and orphan drug, fast track and breakthrough designations.

Discovery

Artificial Intelligence for new uses of psychedelics and combinations with FDA drugs

Development

R&D in combining psychedelics with FDA approved drugs

Delivery

Novel microneedle delivery system for psychedelics

Connect With Us

PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario  Canada
M5C 1P1